By the end of 2024, the company’s gross profit margin reached a record 66.8%, up by 5.5 percentage points from 61.3% in 2023.

This dividend growth stock is hiding in plain sight and has plenty of room to grow its dividend per share over the long run.

Teva Pharmaceutical ( TEVA -1.08%) is my worst-performing stock so far in 2025, down 27% in less than three months as of this ...

Not all corners of the market are moving in the same direction this year; 2025 has already delivered a few surprises for sector-focused investors ...

Mobile advertising company Liftoff is bringing together inspirational women from across the mobile industry to share their stories. In this series, we’ll explore their achievements, the challenges ...

X, formerly known as Twitter, is set to experience its first advertising revenue growth since Elon Musk’s acquisition, driven ...

Ramp explains how business credit cards can help separate those expenses from your personal finances, have higher spending ...

The report showed that in 2024, China's digital industry generated 35 trillion yuan ($4.8 trillion) in business revenue, up 5.5% year on year. Profits rose 3.5% to 2.7 trillion yuan. The sector ...

The House Democrats redrafting Governor Maura Healey’s budget won’t adopt her plan to add new taxes on prescription drugs, ...

Elon Musk's X is on pace for its first year of advertising revenue growth since the billionaire acquired the company in 2022, ...

X is projected to see its ad sales jump significantly, in the latest sign Elon Musk's platform is in the midst of a business ...

Elon Musk’s X is on pace for its first year of advertising revenue growth since the billionaire took over Twitter as his ties ...